CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $20,291,281
- in 6 filings, $20.1M under 10b5-1 plans
Net −$20,288,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Sale | −858 | $284.58 | $244K | 26,206 |
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Sale | −387 | $285.16 | $110K | 25,819 |
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Option exercise · Stock Options (Right to Buy) | −3,846 | 0 | ||
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Option exercise · Stock Options (Right to Buy) | −3,304 | 3,305 | ||
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Option exercise · Stock Options (Right to Buy) | −1,815 | 5,446 | ||
| 2022-02-28 | Smith David Ross Corporate Executive VP & CFO | Grant or award | +5,152 | 25,819 | ||
| 2022-02-23 | FOSTER JAMES C Chairman, President and CEO | Option exercise | +20,296 | $109.34 | $2.2M | 235,318 |
| 2022-02-23 | FOSTER JAMES C Chairman, President and CEO | Sale | −1,503 | $283.89 | $427K | 233,815 |
| 2022-02-23 | FOSTER JAMES C Chairman, President and CEO | Sale | −3,415 | $284.79 | $973K | 230,400 |
| 2022-02-23 | FOSTER JAMES C Chairman, President and CEO | Sale | −2,027 | $286.06 | $580K | 228,373 |
| 2022-02-23 | FOSTER JAMES C Chairman, President and CEO | Sale | −3,171 | $287.10 | $910K | 225,202 |
| 2022-02-23 | FOSTER JAMES C Chairman, President and CEO | Sale | −4,245 | $287.84 | $1.2M | 220,957 |
| 2022-02-23 | FOSTER JAMES C Chairman, President and CEO | Sale | −805 | $288.82 | $233K | 220,152 |
| 2022-02-23 | FOSTER JAMES C Chairman, President and CEO | Sale | −1,078 | $290.01 | $313K | 219,074 |
| 2022-02-23 | FOSTER JAMES C Chairman, President and CEO | Sale | −1,259 | $291.05 | $366K | 217,815 |
| 2022-02-23 | FOSTER JAMES C Chairman, President and CEO | Sale | −981 | $291.81 | $286K | 216,834 |
| 2022-02-23 | FOSTER JAMES C Chairman, President and CEO | Sale | −746 | $292.87 | $218K | 216,088 |
| 2022-02-23 | FOSTER JAMES C Chairman, President and CEO | Sale | −325 | $293.81 | $95K | 215,763 |
| 2022-02-23 | FOSTER JAMES C Chairman, President and CEO | Sale | −389 | $294.70 | $115K | 215,374 |
| 2022-02-23 | FOSTER JAMES C Chairman, President and CEO | Sale | −352 | $295.70 | $104K | 215,022 |
Page 31 of 41 · 819 trades